Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $165 Million - $185 Million
-600,000 Reduced 75.0%
200,000 $56.3 Million
Q2 2021

Aug 16, 2021

BUY
$251.87 - $278.14 $101 Million - $111 Million
400,000 Added 100.0%
800,000 $221 Million
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $65.4 Million - $69.4 Million
400,000 New
400,000 $67.7 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track Gabriel Plotkin's Portfolio

Track Gabriel Plotkin Portfolio

Follow Gabriel Plotkin (Melvin Capital Management LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Melvin Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Melvin Capital Management LP and Gabriel Plotkin with notifications on news.